"Global Drug Discovery Services Market Overview:
Global Drug Discovery Services Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Drug Discovery Services Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Drug Discovery Services involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Drug Discovery Services Market:
The Drug Discovery Services Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Drug Discovery Services Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drug Discovery Services Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Drug Discovery Services market has been segmented into:
Target Selection
Target Validation
Hit to Lead Identification
Lead Optimization
Candidate Validation
By Application, Drug Discovery Services market has been segmented into:
DMPK
Biology Services
Medicinal Chemistry
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Discovery Services market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Discovery Services market.
Top Key Players Covered in Drug Discovery Services market are:
Abbott Laboratories Inc.
Advinus Therapeutics
Agilent Technologies Ubiquigent
Albany Molecular Research Inc.
AstraZeneca PLC
Aurigene
Bayer AG
Charles River Laboratories International
ChemBridge Corporation
Covance
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Drug Discovery Services Market by Type
4.1 Drug Discovery Services Market Snapshot and Growth Engine
4.2 Drug Discovery Services Market Overview
4.3 Target Selection
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Target Selection: Geographic Segmentation Analysis
4.4 Target Validation
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Target Validation: Geographic Segmentation Analysis
4.5 Hit to Lead Identification
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hit to Lead Identification: Geographic Segmentation Analysis
4.6 Lead Optimization
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Lead Optimization: Geographic Segmentation Analysis
4.7 Candidate Validation
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Candidate Validation: Geographic Segmentation Analysis
Chapter 5: Drug Discovery Services Market by Application
5.1 Drug Discovery Services Market Snapshot and Growth Engine
5.2 Drug Discovery Services Market Overview
5.3 DMPK
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 DMPK: Geographic Segmentation Analysis
5.4 Biology Services
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Biology Services: Geographic Segmentation Analysis
5.5 Medicinal Chemistry
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Medicinal Chemistry: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Drug Discovery Services Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ADVINUS THERAPEUTICS
6.4 AGILENT TECHNOLOGIES UBIQUIGENT
6.5 ALBANY MOLECULAR RESEARCH INC.
6.6 ASTRAZENECA PLC
6.7 AURIGENE
6.8 BAYER AG
6.9 CHARLES RIVER LABORATORIES INTERNATIONAL
6.10 CHEMBRIDGE CORPORATION
6.11 COVANCE
Chapter 7: Global Drug Discovery Services Market By Region
7.1 Overview
7.2. North America Drug Discovery Services Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Target Selection
7.2.4.2 Target Validation
7.2.4.3 Hit to Lead Identification
7.2.4.4 Lead Optimization
7.2.4.5 Candidate Validation
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 DMPK
7.2.5.2 Biology Services
7.2.5.3 Medicinal Chemistry
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Drug Discovery Services Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Target Selection
7.3.4.2 Target Validation
7.3.4.3 Hit to Lead Identification
7.3.4.4 Lead Optimization
7.3.4.5 Candidate Validation
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 DMPK
7.3.5.2 Biology Services
7.3.5.3 Medicinal Chemistry
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Drug Discovery Services Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Target Selection
7.4.4.2 Target Validation
7.4.4.3 Hit to Lead Identification
7.4.4.4 Lead Optimization
7.4.4.5 Candidate Validation
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 DMPK
7.4.5.2 Biology Services
7.4.5.3 Medicinal Chemistry
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Drug Discovery Services Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Target Selection
7.5.4.2 Target Validation
7.5.4.3 Hit to Lead Identification
7.5.4.4 Lead Optimization
7.5.4.5 Candidate Validation
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 DMPK
7.5.5.2 Biology Services
7.5.5.3 Medicinal Chemistry
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Drug Discovery Services Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Target Selection
7.6.4.2 Target Validation
7.6.4.3 Hit to Lead Identification
7.6.4.4 Lead Optimization
7.6.4.5 Candidate Validation
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 DMPK
7.6.5.2 Biology Services
7.6.5.3 Medicinal Chemistry
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Drug Discovery Services Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Target Selection
7.7.4.2 Target Validation
7.7.4.3 Hit to Lead Identification
7.7.4.4 Lead Optimization
7.7.4.5 Candidate Validation
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 DMPK
7.7.5.2 Biology Services
7.7.5.3 Medicinal Chemistry
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Drug Discovery Services Scope:
|
Report Data
|
Drug Discovery Services Market
|
|
Drug Discovery Services Market Size in 2025
|
USD XX million
|
|
Drug Discovery Services CAGR 2025 - 2032
|
XX%
|
|
Drug Discovery Services Base Year
|
2024
|
|
Drug Discovery Services Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories Inc., Advinus Therapeutics, Agilent Technologies Ubiquigent, Albany Molecular Research Inc., AstraZeneca PLC, Aurigene, Bayer AG, Charles River Laboratories International, ChemBridge Corporation, Covance.
|
|
Key Segments
|
By Type
Target Selection
Target Validation
Hit to Lead Identification
Lead Optimization
Candidate Validation
By Applications
DMPK
Biology Services
Medicinal Chemistry
|
